PUBCHEM ID | 36822 |
Molecular Weight (g/mol) | 134.182 |
Molecular Formula | C8H10N2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
IUPAC Name | 5,6,7,8-Tetrahydroquinoxaline |
Canonical SMILES | c2cnc1CCCCc1n2 |
PUBCHEM IUPAC INCHIKEY | XCZPDOCRSYZOBI-UHFFFAOYSA-N |
Solubility Level | 4 |
Vapour Pressure |
XLOGP3 AA | NA |
CACTVS TPSA | 26.3 |
BBB Level | 2 |
Absorption Level | 0 |
EXT PPB#Prediction | 0 |
AlogP98 | 1.056 |
EXT CYP2D6#Prediction | 0 |
Mouse Female FDA | Multi-Carcinogen |
Mouse Male FDA | Multi-Carcinogen |
Rat Female FDA | Single-Carcinogen |
Rat Male FDA | Multi-Carcinogen |
Ames Prediction | Non-Mutagen |
Developmental / Reproductive Toxicity | Non-Toxic |
Rat Oral LD50 | 0.922657 |
Ocular Irritancy | Severe |
Hepatotoxic#Prediction | 1 |
Effected Human Genes | NA |
Aerobic Biodegradability Prediction | Non-Degradable |
Physical hazards | not classified |
Health hazards | Mild |
Environmental hazards | not classified |
Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
---|---|---|---|---|---|---|
1 | 34413-35-9 |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|---|---|---|---|---|
1 | 34413-35-9 | Cyclohexapyrazine |